Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Trials and Tribulations of New Agents, Novel Biomarkers, and Retarding Renal Progression — Robert D. Toto (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Trials and Tribulations of New Agents, Novel Biomarkers, and Retarding Renal Progression
Shared by
Giuseppe Remuzzi
Trials and Tribulations of New Agents, Novel Biomarkers, and Retarding Renal Progression
Article
2011
en
Authors
+6 more
RT
Robert D. Toto
Giuseppe Remuzzi
GM
Giuseppe Maschio
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2003
Retarding progression of chronic renal disease: The neglected issue of residual proteinuria
Piero Ruggenenti
,
Annalisa Perna
,
Giuseppe Remuzzi
,
Investigators of the Gisen Group
Letter
2002
The trials and tribulations of anti–IL-5 …
Trevor T. Hansel
,
Peter Sterk
,
Stephen T. Holgate
,
Peter J Barnes
Article
2016
Novel Biomarkers for Renal Diseases? None for the Moment (but One)
Giorgio Gentile
,
Giuseppe Remuzzi
Article
2012
Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment
Asher Chanan‐Khan
,
Jesús F. San Miguel
,
Sundar Jagannath
,
Heinz Ludwig
,
Meletios A Dimopoulos
Article
2020
Trials and tribulations of coronavirus disease-2019 research: with a few bright lights in the fog
Giuseppe Di Pasquale
,
Aldo Maggioni
,
Cristina Gervasoni
,
Felicita Andreotti
.webp)
Discussion(0)
No comments yet. Be the first to comment.